miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke

E-ISSN： 2211-5374|7|1|38-53

ISSN： 2211-5366

Source： MicroRNA, Vol.7, Iss.1, 2018-04, pp. : 38-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells

By Guo Haizhou Li Qianping Li Weihao Zheng Tianliang Zhao Song Liu Zhangsuo

Molecular and Cellular Biochemistry, Vol. 390, Iss. 1-2, 2014-05 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

miR‐134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non‐small cell lung cancer cells

FEBS Open Bio, Vol. 586, Iss. 20, 2012-10 ,pp. : 3761-3765

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical value of miR‐193a‐3p in non‐small cell lung cancer and its potential molecular mechanism explored in silico using RNA‐sequencing and microarray data

FEBS Open Bio, Vol. 8, Iss. 1, 2018-01 ,pp. : 94-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

The development of immunotherapies for non-small cell lung cancer

By Salgaller Michael L

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 265-278

Informa Healthcare

Access to resources Recommend Favorite

Cetuximab in non-small cell lung cancer

By Ademuyiwa Foluso O Hanna Nasser

Expert Opinion on Biological Therapy, Vol. 8, Iss. 1, 2008-01 ,pp. : 107-113

Informa Healthcare

Access to resources Recommend Favorite